Article Text

Download PDFPDF

An essential accessory
  1. David Prince1,
  2. Radha Popuri2,
  3. Avik Majumdar1,3
  1. 1AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
  2. 2Department of Radiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
  3. 3Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia
  1. Correspondence to Dr Avik Majumdar; Avik.Majumdar{at}health.nsw.gov.au

Abstract

A young adult male was referred for a second opinion of deranged liver biochemistry. He initially presented two years prior with abdominal pain, lethargy and fevers due to a segment two pyogenic liver abscess. He received empirical antibiotic therapy to resolution. Computed tomography for abscess follow-up revealed an intrahepatic inferior vena cava thrombus. He was anti-coagulated with warfarin. He was lupus anticoagulant positive and had a highly positive beta-2 glycoprotein antibody on serial measurement and was diagnosed with anti-phospholipid syndrome. On current review, the patient had no clinical stigmata of chronic liver disease. There were dilated veins on the supraumbilical abdominal and chest walls. There was mild hepatomegaly but no splenomegaly. Laboratory investigations revealed mildly cholestatic liver function tests with hyperbilirubinaemia (40μmol/L) but no liver synthetic dysfunction. Serological screening did not reveal any cause of chronic liver disease. The patient underwent multiphase abdominal CT and formal hepatic venography. What is the diagnosis and describe the hepatic venous outflow?

  • budd chiari syndrome
  • venous thrombosis
  • liver

Data availability statement

Data sharing not applicable as no datasets generated and/or analysed for this study.

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Question

A young adult male was referred for a second opinion of deranged liver biochemistry. He initially presented 2 years prior with abdominal pain, lethargy and fevers due to a segment two pyogenic liver abscess. He received empirical antibiotic therapy to resolution. CT for abscess follow-up revealed an intrahepatic inferior vena cava (IVC) thrombus. He was anticoagulated with warfarin. He was lupus anticoagulant positive and had a highly positive beta-2 glycoprotein antibody on serial measurement and was diagnosed with antiphospholipid syndrome (APS).

On current review, the patient had no peripheral clinical stigmata of chronic liver disease. There were dilated veins on the supraumbilical abdominal and chest walls. There was mild hepatomegaly but no splenomegaly. Laboratory investigations revealed mildly cholestatic liver function tests with hyperbilirubinaemia (40 µmol/L) but no liver synthetic dysfunction. Serological screening did not reveal any cause of chronic liver disease. He did not have antibodies to Echinoccoccus granulosus or Fasciola hepatica.

The patient underwent multiphase abdominal CT and formal hepatic venography (figures 1–6).

Figure 1

Venous phase CT demonstrating thrombus occluding the entire intrahepatic IVC. The hepatic veins are not visualised however a dilated accessory inferior right hepatic vein (AIRHV) can be seen. IVC, inferior vena cava.

Figure 2

Cavogram of patient IVC superior to thrombosis. The hepatic veins could not be catheterised. IVC, inferior vena cava.

Figure 3

Cavogram of the patent IVC inferior to the thrombosis.

Figure 4

Selective catheterisation of the AIRHV with angiography demonstrating near complete occlusion of the right and middle hepatic vein ostia with aberrant intrahepatic venous collaterals allowing hepatic venous outflow via the AIHRV. Blue arrows denote direction of blood flow.

Figure 5

Selective catheterisation of the AIRHV with further demonstration of aberrant intrahepatic and extrahepatic collaterals to allow for hepatic venous outflow.

Figure 6

Lateral angiographic view demonstrating occluded IVC with collateralisation of paralumbar veins.

What is the diagnosis and describe the hepatic venous outflow?

Answer

There is ongoing occlusive thrombus of the intrahepatic IVC and the hepatic vein ostia in the context of APS (figures 1–3). The main hepatic veins are not visualised; however, a dilated accessory inferior right hepatic vein (AIRHV) is seen. Figure 2 is a cavogram of patent IVC superior to the thrombosis. The hepatic veins could not be catheterised.

Unusually in this case, there were no features of Budd-Chiari syndrome (BCS). BCS is characterised by partial or complete hepatic venous outflow obstruction, which causes increased hepatic sinusoid pressure and hepatocyte hypoxia.1 Patients may present acutely with abdominal pain, ascites, hepatomegaly and liver failure, but can occasionally be asymptomatic and present subsequently with features of chronic liver disease.2

In this case, hepatic venous outflow was predominantly via a dilated AIRHV, which drained directly into the IVC below the thrombosis (figure 4). Aberrant collaterals from the middle hepatic to the AIRHV were demonstrated on venography (figures 4–5). Blood from the IVC returns to the right atrium via collateralised paralumbar and azygos veins (figure 3, figure 6). Accessory right hepatic veins are present in 30% of patients3 and in this case, the accessory vein was an essential compensatory vessel to allow hepatic venous outflow and avoid BCS.

Data availability statement

Data sharing not applicable as no datasets generated and/or analysed for this study.

Ethics statements

Patient consent for publication

References

Footnotes

  • Contributors All authors contributed equally.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.